CTRB2 p.Ile121Leu
c.361A>C · VCV4008103
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2892 | likely benign |
|---|---|---|
| REVEL | 0.661 | pathogenic-leaning |
| SaProt | LLR -9.63 | tolerated |
| ⇒ REVEL calls this damaging; AlphaMissense and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 2.3 | GERP 1.3, phastCons 1 |
| Regional constraint | o/e 0.09 | constrained · MANE · 1,077 bp · p 4.7e-13 · regional, not allelic |
| Overall | ||
| CADD | 23.2 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.0149% | 6,695 |
| Admixed American | 0.0134% | 7,451 |
| Remaining individualsnot grpmax-eligible | 0.00446% | 22,436 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CTRB2
- Protein
- p.Ile121Leu
- Coding
- c.361A>C
- MANE Select
- NM_001025200
- Type
- single nucleotide variant
- Location
- chr16:75205468 (GRCh38)
- Gene constraint
- LOEUF 1.168 · pLI 0.36 (gnomAD)
- Structure
- AlphaFold pLDDT 91.79
- Residue 121
- the peptidase s1 domain; a disulfide bond
Similar variants
- CTRB2 p.Ala11Thr Uncertain significance ★ ⚠ same type
- CTRB2 p.Ala138Thr Uncertain significance ★ ⚠ same type
- CTRB2 p.Ala244Thr Uncertain significance ★ ⚠ same type
- CTRB2 p.Arg131His Uncertain significance ★ ⚠ same type
- CTRB2 p.Arg236Cys Uncertain significance ★ ⚠ same type
- CTRB2 p.Arg236His Uncertain significance ★ ⚠ same type
- CTRB2 p.Arg248Cys Uncertain significance ★ ⚠ same type
- CTRB2 p.Asn167Tyr Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ctrb2-p-ile121leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown